| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0067 | 0.9 |